Cytokines in Parasitic Diseases: The Example of Cutaneous Leishmaniasis

References

• Grau G. E., Piguet P. F., Vassali P., Lambert P. H. Tumor necrosis factor and other cytokines in cerebral malaria: experimental and clinical data. Immunol. Res. 1989; 112: 49–70
   Google Scholar
• Mosmann T. R., Coffman R. L. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 1989; 7: 145–173
   PubMed Web of Science ®Google Scholar
• Romagnani S. Th1 and Th2 in human diseases. Clin. Immunol. & Immunopathology 1996; 80: 225–235
   PubMedGoogle Scholar
• Zurawski G., de Vries J. E. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunology today 1994; 15: 19–26
   PubMedGoogle Scholar
• Röcken M., Saurat J. H., Hauser C. A common precursor for CD4+ T cells producing IL-2 and IL-4. J. Immunol. 1992; 148: 1031–1036
   PubMed Web of Science ®Google Scholar
• Kamogawa Y., Minasi L.-A., Carding S. R., Bottomly K., Flavell R. A. The realtionship of IL-4- and IFNγ-producing T cells studied by lineage ablation of IL-4 producing cells. Cell 1993; 75: 985–995
   PubMed Web of Science ®Google Scholar
• Croft M., Carter L., Swain S. L., Dutton R. W. Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profile. J. Exp. Med. 1994; 180: 1715–1728
   PubMed Web of Science ®Google Scholar
• Mosmann T. R., Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. today 1996; 17: 138–146
   PubMedGoogle Scholar
• Ferrick D. A., Schrenzel M. D., Mulvania T., Hsieh B., Ferlin W. G., Lepper H. Differential production of interferon-γ and interleukin-4 in response to Th1- and Th2-stimulating pathogens by γ/δ T cells in vivo. Nature (Lond.) 1995; 373: 255–257
   PubMed Web of Science ®Google Scholar
• Yoshimoto T., Paul W. E. CD4 pos, NK1.1 pos T cells promptly produce interleukin 4 in response to in vivo, challenge with anti-CD3. J. Exp. Med. 1994; 179: 1285–1295
   PubMed Web of Science ®Google Scholar
• Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 1995; 13: 251–276
   PubMed Web of Science ®Google Scholar
• Moore K. W., O'Garra A., de Waal Malefyt R., Vieira P., Mosmann T. R. Interleukin-10. Annu. Rev. Immunol. 1993; 11: 165–190
   PubMed Web of Science ®Google Scholar
• Fitch F. W., McKisic M. D., Lancki D. W., Gajewski T. F. Differential regulation of murine T lymphocyte subsets. Annu. Rev. Immunol. 1993; 11: 29–48
   PubMed Web of Science ®Google Scholar
• Fiorentino D. F., Bond M. W., Mossman T. R. Two types of mouse T helper cell. IV Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 1989; 170: 2081–2095
   PubMed Web of Science ®Google Scholar
• Locksley R. M., Heinzel F. P., Sadick M. D., Holaday B. J., Gardner K. D. Murine cutaneous leishmaniasis: Susceptibility correlates with differential expansion of helper T cell subset. Ann. Inst. Pasteur/Immunol. 1987; 138: 744–749
   PubMedGoogle Scholar
• Heinzel F. P., Sadick M. D., Holaday B. J., Coffman R. L., Locksley R. M. Reciprocal expression of interferon γ or interleukin 4 during the resolution or progression of murine leishmaniasis. J. Exp. Med. 1989; 169: 59–72
   PubMed Web of Science ®Google Scholar
• Nickell S. P., Keane M., So M. Further characterization of protective Trypanosoma cruzi,-specific CD4+ T cell clones T helper type 1-like phenotype and reactivity with shed trypomastigote antigens. Infect. Immun. 1993; 61: 3250–3258
   Google Scholar
• Oswald I. P., Caspar P., Jankovic D., Wynn T. A., Pearce E. J., Sher A. IL-12 inhibits Th2 cytokine responses induced by eggs of Shistosoma. J. Immunol. 1994; 153: 1707–1713
   PubMed Web of Science ®Google Scholar
• Behin R., Mattel J., Sordat B. Leishmania tropica:, pathogenicity and in vitro, macrophage function of inbred mice. Exp. Parasitology 1979; 48: 81–91
   PubMed Web of Science ®Google Scholar
• Mitchell G. F., Curtis J. M., Scollay R. G., Handman E. Resistance and abrogation of resistance to cutaneous leishmaniaisis in reconstituted BALB/c mice. Aust. J. Exp. Biol. Med. Sci. 1981; 59: 539–544
   PubMedGoogle Scholar
• Milon G., Titus R. G., Cerottini J. C., Marchal G., Louis J. A. Higher frequency of Leishmania major-specific, L3T4+ T cells in susceptible BALB/c as compared with resistant CBA mice. J. Immunol. 1986; 136: 1467–1471
   PubMed Web of Science ®Google Scholar
• Titus R. G., Milon G., Marchal G., Vassalli P., Cerottini J. C., Louis J. A. Involvement of specific Lyt-2+ T cells in the immunological control of experimentally induced murine cutaneous leishmaniasis. Eur. J. Immunol. 1987; 17: 1429–33
   PubMed Web of Science ®Google Scholar
• Liew F. Y. Functional heterogeneity of CD4+ T cells in leishmaniasis. Immunol. today 1989; 10: 40–45
   PubMedGoogle Scholar
• Sadick M. D., Heinzel F. P., Holaday B. J., Pu R. T., Dawkins R. S., Locksley R. M. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon-γ independent mechanism. J. Exp. Med. 1990; 171: 115–127
   PubMed Web of Science ®Google Scholar
• Titus R. G., Ceredig R., Cerottini J. C., Louis J. A. Therapeutic effect of anti-L3T4 monoclonal antibody GK1.5 on cutaneous leishmaniasis in genetically-susceptible BALB/c mice. J. Immunol. 1985; 135: 2108–2114
   Google Scholar
• Müller I., Garcia-Sanz J. A., Titus R., Behin R., Louis J. Analysis of the cellular parameters of the immune responses contributing to resistance and susceptibility of mice to infection with the intracellular parasite. Leishmania major, Immunol. Rev. 1989; 112: 95–113
   PubMed Web of Science ®Google Scholar
• Holaday B. J., Sadick M. D., Wang Z.-E., Reiner S. L., Heinzel F. P., Parslow T. G., Locksley R. M. Reconstitution of Leishmania, immunity in severe combined immunodeficient mice using Th1- and Th2-like cell lines. J. Immunol. 1991; 147: 1653–1658
   PubMedGoogle Scholar
• Assreuy J., Cunha F. Q., Epperlein M., Noronha-Dutra A., O'Donnell C. A., Liew F. Y., Moncada S. Production of nitric oxide and superoxide by activated macrophages and killing of Leishmania major. Eur. J. Immunol. 1994; 24: 672–676
   PubMed Web of Science ®Google Scholar
• Wang Z.-E., Reiner S. L., Zheng S., Dalton D. K., Locksley R. M. CD4+ effector cells default to the Th2 pathway in interferon γ-deficient mice infected with Leishmania major. J. Exp. Med. 1994; 179: 1367–1371
   PubMed Web of Science ®Google Scholar
• Swihart K., Fruth U., Messmer N., Hug K., Behin R., Huang S., Del Giudice G., Aguet M., Louis J. A. Mice from a genetically resistant background lacking the interferon gamma receptor are susceptible to infection with Leishmania major, but mount a polarized T helper cell 1-type CD4+ T cell response. J. Exp. Med. 1995; 181: 961–971
   Google Scholar
• Liew F. Y., Millott S., Li Y., Lelchuck R., Chan W. L., Ziltener H. Macrophage activation by interferon-γ from host-protective T cells is inhibited by interleukin (IL) 3 and IL4 produced by disease-promoting T cells in leishmaniasis. Eur. J. Immunol. 1989; 19: 1227–1232
   Google Scholar
• Leal L. M.C.C., Moss D. W., Kuhn R., Muller W., Liew F. Y. Interleukin-4 transgenic mice of resistant background are susceptible to Leishmania major, infection. Eur. J. Immunol. 1993; 23: 566–569
   PubMed Web of Science ®Google Scholar
• Titus R. G., Marchand M., Boon T., Louis J. A. A limiting dilution assay for quantifying Leishmania major, in tissue of infected mice. Parasite Immunol. 1985; 545–555
   Google Scholar
• Aebisher T., Moody S. F., Handman E. Persistence of virulent Leishmania major, in murine cutaneous leishmaniasis: a possible hazard of the host. Infect. Immun. 1993; 61: 220–226
   Google Scholar
• Stenger S., Donhauser N., Thurin H., Rollinghoff M., Bogdan C. Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase. J. Exp. Med. 1996; 183: 1501–1514
   PubMed Web of Science ®Google Scholar
• Seder R. A., Paul W. E., Davis M. M., Fazekas de St Groth B. The presence of interleukin 4 during in vitro, priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice. J. Exp. Med. 1992; 176: 1091–1098
   PubMed Web of Science ®Google Scholar
• Seder R. A., Gazzinelli R., Sher A., Paul W. E. Interleukin 12 acts directly on CD4+ T cells to enhance priming for inteferon-γ production and diminishes interleukin 4 inhibition of such priming. Proc. Natl. Acad. Sci. USA 1993; 90: 10188–10192
   PubMed Web of Science ®Google Scholar
• Hsieh C.-S., Macatonia S. E., Tripp C. S., Wolf S. F., O'Garra A., Murphy K. M. Development of Th1 CD4+ T cells through IL-12 produced by Listeria,-induced macrophages. Science 1993; 260: 547–549
   PubMed Web of Science ®Google Scholar
• Macatonia S. E., Hsieh C.-S., Murphy K. M., O'Garra A. Dendritic cells and macrophages are required for Th1 development of CD4+ T cells from αβ TCR transgenic mice: IL-12 substitution for macrophages to stimulate IFN-γ production is IFN-γ dependent. International Immunology 1993; 5: 1119–1128
   PubMed Web of Science ®Google Scholar
• Schmitt E., Hoehn P., Germann T., Rüde E. Differential effects of interleukin 12 on the development of naive mouse CD4+ T cells. Eur. J. Immunol. 1994; 24: 343–347
   PubMed Web of Science ®Google Scholar
• Kobayashi M., Fitz L., Ryan M., Hewick R. M., Clark S. C., Chau S., Loudon R., Sherman F., Perussia B., Trinchieri G. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biological effects on human lymphocytes. J. Exp. Med. 1989; 170: 827–845
   PubMed Web of Science ®Google Scholar
• Stern A. S., Padlaski F Y., Hulmes J. D., Pan Y. E., Quinn P. M., Wolitzky A. G., Familletti P. C., Stremlo D. L., Trutt T., Chizzonite R., Gately M. K. Purification to homogeneity and partial characterization of cytotoxic lymphocyte factor from human B lymphocytes. Proc. Natl. Acad. Sci. USA 1990; 87: 6808–6812
   PubMed Web of Science ®Google Scholar
• Wolf S. F., Temple P. A., Kobayashi M., Young D., Dicig M., Lowe L., Dzialo R., Fitz L., Ferenz C., Hewick R. M., Kelleher K., Hermann S. M., Clark S. C., Azzoni L., Chan S. H., Trinchieri G., Perussia B. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biological effect on T and natural killer cells. J. Immunol. 1991; 146: 3074–3081
   PubMed Web of Science ®Google Scholar
• Chan S. H., Perussia B., Gupta J. W., Kobayashi M., Pospisil M., Young H. A., Wolf S. F., Young D., Clark S. C., Trinchieri G. Induction of IFN-γ production by NK cell stimulatory factor (NKSF): characterization of the responder cells and synergy with other inducers. J. Exp. Med. 1991; 173: 689–879
   Google Scholar
• D'Andrea A., Rengaraju M., Valiante N. M., Chehimi J., Kubin M., Aste M., Chan S. H., Kobayashi M., Young D., Nickbarg E., Chizzonite R., Wolf S. F., Trinchieri G. Production of natural killer cell stimulatory factor (interleukin-12) by peripheral blood mononuclear cells. J. Exp. Med. 1992; 176: 1387–1398
   PubMed Web of Science ®Google Scholar
• Heinzel F. P., Schoenhaut D. S., Rerko R. M., Rosser L. E., Gately M. K. Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. Med. 1993; 177: 1505–1509
   PubMed Web of Science ®Google Scholar
• Sypek J. P., Chung C. L., Mayor S. E.H., Subramanyam S. J., Goldman S. J., Sieburth D. S., Wolf S. F., Schaub R. G. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J. Exp. Med. 1993; 177: 1793–1802
   Google Scholar
• Heinzel F. P., Rerko R. M., Ahmed F., Pearlman E. Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating Leishmaniasis in normally resistant mice. J. Immunol. 1995; 155: 730–739
   PubMed Web of Science ®Google Scholar
• Wynn T. A., Eltoum I., Oswald L P., Cheever A. W., Sher A. Endogenous IL-12 regulates granuloma formation induced by eggs of Schistosoma mansoni, and exogenous IL-12 both inhibits and prophylactically immunizes against egg pathology. J. Exp. Med. 1994; 179: 1551–1561
   PubMed Web of Science ®Google Scholar
• Finkelmann F. D., Madden K. D., Cheever A. W., Katona I. M., Morris S. C., Gately M. K., Hubbard B. R., Gause W. C., Urban J. F.J. Effects of interleukin-12 on immune response and host protection in mice infected with intestinal nematode parasites. J. Exp. Med. 1994; 179: 1563–1572
   Google Scholar
• Magram J., Connaughton S. E., Warrier R. R., Carvajal D. M., Wu C.-Y., Ferrante J., Stewart C., Sarmiento Y., Faherty D. A., Gately M. K. IL-12-deficient mice are defective in IFN-γ production and type 1 cytokine responses. Immunity 1996; 4: 471–481
   PubMed Web of Science ®Google Scholar
• Mattner F., Magram J., Ferrante J., Launois P., Di Padova K., Behin R., Gately M. K., Louis J. A., Alber G. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major, and mount a polarized Th2 cell response. Eur. J. Immunol. 1996; 26: 1553–1559
   PubMed Web of Science ®Google Scholar
• Reiner S. L., Zheng S., Wang Z. E., Stowring L., Locksley R. M. Leishmania, promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection. J. Exp. Med. 1994; 179: 447–456
   PubMed Web of Science ®Google Scholar
• Vieira L. Q., Hondowicz B. D., Afonso L. C.C., Wysocka M., Trinchieri G., Scott P. Infection with Leishmania major, induces interleukin-12 production in vivo. Immunology letters 1994; 40: 157–161
   PubMed Web of Science ®Google Scholar
• Scharton-Kersten T., Afonso L. C.C., Wysocka M., Trinchieri G., Scott P. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J. Immunol. 1995; 154: 5320–5330
   PubMed Web of Science ®Google Scholar
• Afonso L. C.C., Sharton T. M., Vieira L. Q., Wysocka M., Trinchieri G., Scott P. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 1994; 263: 235–237
   PubMed Web of Science ®Google Scholar
• Güler M. L., Gorham J. D., Hsieh C. S., Mackey A. J., Steen R. G., Dietrich W. F., Murphy K. M. Genetic susceptibility to Leishmania:, IL-12 responsiveness in Th1 cell development. Science 1996; 271: 984–987
   PubMed Web of Science ®Google Scholar
• Coffman R. L., Varkila K., Scott P., Chatelain R. Role of cytokines in the differentiation of CD4+ Tcell subsets in vivo. Immunol. Rev. 1991; 123: 189–205
   PubMed Web of Science ®Google Scholar
• Pernis A., Gupta S., Gollob K. J., Garfein E., Coffman R. L., Schindler C., Rothman P. Lack of interferon-γ receptor β chain and the prevention of interferon γ signaling in Th1 cells. Science 1995; 269: 245–247
   PubMed Web of Science ®Google Scholar
• Wenner C. A., Güler M. L., Macatonia S. E., O'Garra A., Murphy K. M. Roles of IFN-γ and IFN-α in IL-12-induced T helper cell-1 development. J. Immunol. 1996; 156: 1442–1447
   PubMed Web of Science ®Google Scholar
• Szabo S. J., Dighe A. S., Gubler U., Murphy K. M. Regulation of the interleukin (IL)-12R β2 subunit expression in developing T helper (Th1) and Th2 cells. J. Exp. Med. 1997; 185: 817–824
   PubMed Web of Science ®Google Scholar
• Skeen M. J., Mille M. A., Shinnick T. M., Ziegler H. K. Regulation of murine macrophage IL-12 production. Activation of macrophages in vivo, restimulation in vitro, and modulation by other cytokines. J. Immunol. 1996; 156: 1196–1206
   PubMed Web of Science ®Google Scholar
• Snidjers A., Hilkens C. M.U., van der Pouw Kraan T. C.T.M., Engel M., Aarden L. A., Kapsenberg M. L. Regulation of bioactive IL-12 production in liposaccharide-stimulated human monocyte is determined by the expression of the p35 subunit. J. Immunol. 1996; 156: 1207–1212
   PubMed Web of Science ®Google Scholar
• Ma X., Chow J. M., Gri G., Carra G., Gerosa F., Wolf S. F., Dzialo R., Trinchieri G. The interleukin 12 p40 gene promoter is primed by interferon-γ in monocytic cells. J. Exp. Med. 1996; 183: 147–157
   PubMed Web of Science ®Google Scholar
• Flesch I. E., Hess J. H., Huang S., Aguet M., Rothe J., Bluethmann H, Kaufmann S. H.E. Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon γ and tumor necrosis factor α. J. Exp. Med. 1995; 181: 1615–1621
   PubMed Web of Science ®Google Scholar
• Belosevic M., Finbloom D. S., van der Meide P. H., Slayter M. V., Nacy C. A. Administration of monoclonal anti-IFN-γ antibodies in vivo, abrogates natural resistance of C3H/HeN mice to infection with Leishmania major. J. Immunol. 1989; 143: 266–274
   PubMed Web of Science ®Google Scholar
• Scott P. A. IFN-γ modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. J. Immunol. 1991; 147: 3149–3155
   PubMed Web of Science ®Google Scholar
• Hsieh C.-S., Macatonia S. E., O'Garra A., Murphy K. M. Pathogen-induced Th1 phenotype development in CD4+ αβ-TCR transgenic T cells is macrophage dependent. International Immunology 1993; 5: 371–382
   PubMedGoogle Scholar
• Corry D. B., Reiner S. L., Linsley P. S., Locksley R. M. Differential effects of blockade of CD28-B7 on the development of Th1 or Th2 effector cells in experimental leishmaniasis. J. Immunol. 1994; 153: 4142–4148
   Google Scholar
• Heinzel F. P., Rerko R. M., Hatam F., Locksley R. M. IL-2 is necessary for the progression of leishmaniasis in susceptible murine hosts. J. Immunol. 1993; 150: 3924–3931
   PubMed Web of Science ®Google Scholar
• Launois P., Ohteki T., Swihart K., MacDonald H. R., Louis J. A. In susceptible mice, Leishmania major, induce very rapid interleukin-4 production by CD4+ T cells which are NK 1.1-. Eur. J. Immunol. 1995; 25: 3298–3307
   PubMed Web of Science ®Google Scholar
• Launois P., Swihart K., Milon G., Louis J. A. Early production of IL-4 in susceptible mice infected with Leishmania major, rapidly induces IL-12 unresponsiveness. J. Immunol. 1997; 158: 3317–3324
   PubMed Web of Science ®Google Scholar
• Paul W. E., Seder R. A., Plaut M. Lymphokine and cytokine production by Fc epsilon RI+ cells. Adv. Immunol. 1993; 53: 1–29
   PubMedGoogle Scholar
• Sabin E. A., Pearce E. J. Early IL-4 production by non-CD4+ cells at the site of antigen deposition predicts the development of a T helper 2 cell response to Schistosoma mansoni eggs. J. Immunol. 1995; 155: 4844–4853
   Google Scholar
• Bendelac A., Lantz O., Quimby M. E., Yewdell J. W., Bennink J. R., Brutkiewicz R. R. CD1 recognition by mouse NK 1+ T lymphocytes. Science 1995; 268: 863–865
   PubMed Web of Science ®Google Scholar
• Arase H., Arase N., Ogasawara K., Good R. A., Onoe K. An NK 1.1+ CD4+8- single-positive thymocyte subpopulation that expresses a highly skewed T-cell antigen receptor Vβ family. Proc. Natl. Acad. Sci. USA 1992; 89: 6506–6512
   PubMed Web of Science ®Google Scholar
• Ohteki T., MacDonald H. R. Stringent V beta requirement for the development of NK 1.1+ T cell receptor-alpha/beta+ cells in mouse liver. J. Exp. Med. 1994; 180: 395–382
   Google Scholar
• Yoshimoto T., Bendelac A., Watson C., Hu-Li J., Paul W. E. Role of NK 1.1+ T cells in a Th2 response and in immunoglobulin E production. Science 1995; 270: 1845–1847
   PubMed Web of Science ®Google Scholar
• Yoshimoto T., Bendelac A., Hu-Li J., Paul W. E. Defective IgE production by SJL mice is linked to the absence of CD4+ NK 1.1+ T cells that promptly produce interleukin 4. Proc. Natl. Acad. Sci. USA 1995; 92: 11931–11934
   PubMed Web of Science ®Google Scholar
• von der Weid T., Beebe A. M., Roopenian D. C., Coffman R. L. Early production of IL-4 and induction of Th2 responses in the lymph nodde originate from an MHC class I-independent CD4+ NK 1.1- T cell population. J. Immunol. 1996; 157: 4421–4427
   Google Scholar
• Brown D. R., Fowell D. J., Corry D. B., Wynn T. A., Moskowitz N M., Cheever A. W., Locksley R. M., Reiner S. L. β2-microglobulin-dependent NK 1.1+ T cells are nor essential for T helper cell 2 immune responses. J. Exp. Med. 1996; 184: 1295–1304
   PubMed Web of Science ®Google Scholar
• Launois P., Maillard I., Pingel S., Swihart K., Xenarios I., Acha-Orbea H., Diggelmann H., Locksley R. M., MacDonald H. R., Louis J. A. IL-4 rapidly produced by Vβ4 Vα8 CD4+ T cells in BALB/c mice infected with Leishmania major, instructs Th2 cell development and susceptibility to infection. Immunity 1997; 6: 541–549
   PubMed Web of Science ®Google Scholar
• Reiner S. L., Wang Z.-E., Hatam F., Scott P., Locksley R. M. TH1 and TH2 cell antigen receptors in experimental leishmaniasis. Science 1993; 259: 1457–1460
   PubMed Web of Science ®Google Scholar
• Mougneau E., Altare F., Wakil A. E., Zheng S., Coppola T., Wang Z.-E., Waldmann R., Locksley R. M., Glaichenhaus N. Expression cloning of a protective Leishmania, antigen. Science 1995; 268: 563–566
   PubMed Web of Science ®Google Scholar
• Julia V., Rassoulzadegan M., Glaichenhaus N. Resistance to Leishmania major, induced by tolerance to a single antigen. Science 1996; 274: 421–423
   PubMed Web of Science ®Google Scholar
• Grewal I. S., Flavell R. A. A central role of CD40 ligand in the regulation of CD4+ T-cell responses. Immunology today 1996; 17: 410–414
   PubMedGoogle Scholar
• Campbell K. A., Ovendale P. J., Kennedy M. K., Fanslow W. C., Reed S. G., Maliszewski C. R. CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 1996; 4: 283–289
   PubMed Web of Science ®Google Scholar
• Kamanaka M., Yu P., Yasui T., Yoshida K., Kawabe T., Horii T., Kishimoto T., Kikutani H. Protective role of CD40 in Leishmania major, infection at two distinct phases of cell-mediated immunity. Immunity 1996; 4: 275–281
   PubMed Web of Science ®Google Scholar
• Brown J. A., Titus R. G., Nabavi N., Glimcher L. H. Blockade of CD86 ameliorates Leishmania major, infection by down regulating the Th2 response. J. Inf. diseases 1996; 147: 1303–1308
   Google Scholar
• Seder R. A., Germain R. N., Linsley P. S., Paul W. E. CD28-mediated costimulation of interleukin 2 (IL2) production plays a critical role in T cell priming for IL-4 and interferon γ production. J. Exp. Med. 1994; 179: 299–304
   PubMed Web of Science ®Google Scholar
• Brown D. R., Green J. M., Moskowitz N. H., Davis M., Thompson C. B., Reiner S. L. Limited role of CD28-mediated signals in T helper subset differentiation. J. Exp. Med. 1996; 184: 803–810
   PubMedGoogle Scholar
• Shinde S., Wu Y., Guo Y., Niu Q., Xu J., Grewal I. S., Flavell R., Liu Y. CD40L is important for induction of, but not response to, costimulatory activity. ICAM-1 as the second costimulatory molecule rapidly upregulated by CD40L. J. Immunol. 1996; 157: 2764–2768
   Google Scholar
• Guo Y., Wu Y., Shinde S., Sy M. S., Auruffo A., Liu Y. Identification of a costimulatory molecule rapidly induced by CD40L as CD44H. J. Exp. Med. 1996; 184: 955–961
   PubMed Web of Science ®Google Scholar
• Reiner S. L., Zheng S., Corry D. B., Locksley R. M. Constructing poly-competitor cDNAs for quantitative PCR. J. Immunol. Meth. 1994; 165: 37–46
   Google Scholar